Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

in 't Veld, Bas A., Ruitenberg, Annemieke, Hofman, Albert, Launer, Lenore J., van Duijn, Cornelia M., Stijnen, Theo, Breteler, Monique M.B., Stricker, Bruno H.C.·2001·New England Journal of Medicine

Cited by (1,000)

Items 801–900 of 1,000

  1. El virus de la inmunodeficiencia humana tipo 1 y el sistema nervioso central en desarrollo.
    Jorge Alejandro Henao, Nora Vanegas‐Arroyave, Oscar D. Cano, Juan Carlos Hiromi, Marı́a Teresa Rugeles · 2005 · Biomédica
  2. A systematic review of amyloid-β peptides as putative mediators of the association between affective disorders and Alzheimer׳s disease
    Leda Abbasowa, Niels H. H. Heegaard · 2014 · Journal of Affective Disorders
  3. [Contribution of omega-3 fatty acids for memory and cognitive function].
    Dan Linetzky Waitzberg, Priscila Garla · 2014 · PubMed
  4. Mild Cognitive Impairment
    2006 · Wiley eBooks
  5. Gut Microbiota and Alzheimer’s Disease: Pathophysiology and Therapeutic Perspectives
    Yanli Li, Rui Wang, Qian Li, Yan‐Jiang Wang, Junhong Guo · 2021 · Journal of Alzheimer s Disease
  6. Naproxen as a potential candidate for promoting rivastigmine anti-Alzheimer activity against aluminum chloride-prompted Alzheimer's-like disease in rats; neurogenesis and apoptosis modulation as a possible underlying mechanism
    Raafat A. Abdel‐Aal, Ola A. Hussein, Reham G. Elsaady, Lobna A. Abdelzaher · 2021 · European Journal of Pharmacology
  7. Amelioration of cognitive ability in senescence-accelerated mouse prone 8 (SAMP8) by intra-bone marrow-bone marrow transplantation
    Ming Li, Muneo Inaba, Kequan Guo, Nader G. Abraham, Susumu Ikehara · 2009 · Neuroscience Letters
  8. EVALUATION OF ANTIOXIDANT, ANTI-ALZHEIMER'S AND ANTI-INFLAMMATORY ACTIVITIES OF ENZYMATIC HYDROLYSATES FROM EDIBLE BROWN SEAWEED (LAMINARIA JAPONICA)
    MAHINDA SEVEVIRATHNE, Ka-Hwa Lee, Chang‐Bum Ahn, Pyo‐Jam Park, Jae‐Young Je · 2011 · Journal of Food Biochemistry
  9. COX-2 expression in brains of patients with familial Alzheimer's disease
    Shigeru Nogawa, Masaki Takao, Shigeaki Suzuki, Kortaro Tanaka, Atsuo Koto, Yasuo Fukuuchi, Isao Hayakawa · 2003 · International Congress Series
  10. Primary Prevention and Delay of Onset of AD/Dementia
    Howard Feldman, Claudia Jacova · 2007 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  11. In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition
    Malvina Hoxha, Carola Buccellati, Valérie Capra, Davide Garella, Clara Cena, Barbara Rolando, Roberta Fruttero, Silvia Carnevali, Angelo Sala, G. Enrico Rovati et al. · 2015 · Pharmacological Research
  12. Aspirin Therapy, Cognitive Impairment, and Dementia—A Review
    Elizabeth H. Thong, Edward C. Y. Lee, Choi-Ying Yun, Tony Yi‐Wei Li, Ching‐Hui Sia · 2023 · Future Pharmacology
  13. Sex‐ and region‐dependent neuroinflammation in Alzheimer's disease
    Maricedes Acosta‐Martínez, Vanessa Carter, Aviram Nessim, Radha Panchal, Dora John, Jasbeer Dhawan, Thomas G. Beach, Geidy E. Serrano, Erin E. Sundermann, Anat R Biegon · 2025 · Alzheimer s & Dementia
  14. Intranasally Administered S100A9 Amyloids Induced Cellular Stress, Amyloid Seeding, and Behavioral Impairment in Aged Mice
    Igor A. Iashchishyn, Грудень Марина Алексеевна, Roman Moskalenko, Tatiana V. Davydova, Chao Wang, Robert D. E. Sewell, Ludmilla A. Morozova‐Roche · 2018 · ACS Chemical Neuroscience
  15. IL-1R-/- alleviates cognitive deficits through microglial M2 polarization in AD mice
    Huanhuan Wang, Guoping Peng, Bing Wang, Hongping Yin, Xingyue Fang, Fangping He, Dongjiu Zhao, Qibing Liu, Liyun Shi · 2020 · Brain Research Bulletin
  16. Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019.
    Dror Shir, Gregory Scott Day · 2022 · PubMed Central
  17. Synthesis of oligo(ethylene glycol) substituted phosphatidylcholines: Secretory PLA2-targeted precursors of NSAID prodrugs
    Renato Rosseto, Joseph Hajdu · 2009 · Chemistry and Physics of Lipids
  18. Antimalarials Inhibit Human Erythrocyte Membrane Acetylcholinesterase
    Subhash D. Katewa, Surendra S. Katyare · 2005 · Drug and Chemical Toxicology
  19. Possible involvement of endoplasmic reticulum stress in the pathogenesis of Alzheimer’s disease
    Toru Hosoi, Jun Nomura, K. Ozawa, A. Nishi, Y. Nomura · 2015 · Endoplasmic Reticulum Stress in Diseases
  20. Effects of NSAIDs on the Dynamics and Phase Behavior of DODAB Bilayers
    DUBEY Purushottam Shashikumar, Veerendra Kumar Sharma, Harish Srinivasan, Subhankur Mitra, Victoria García Sakai, Ramaprosad Mukhopadhyay · 2018 · The Journal of Physical Chemistry B
  21. Intermittent Fasting and Brain Health: Efficacy and Potential Mechanisms of Action
    Nikita Francis · 2020 · OBM Geriatrics
  22. A role for cyclooxygenase-1 in β-amyloid-induced neuroinflammation
    Eduardo Candelario‐Jalil · 2009 · Aging
  23. Medications and Diet
    Claudia H. Kawas · 2006 · Alzheimer Disease & Associated Disorders
  24. Immunological and immunogenetic markers in sporadic Alzheimer’s disease
    Domenico Lio, Letizia Scola, Giuseppina Colonna Romano, Giuseppina Candore, Calogero Caruso · 2006 · Aging Clinical and Experimental Research
  25. Population‐based studies of AD: message and methods: an epidemiologic view
    Lenore J. Launer, D. B. Brock · 2004 · Statistics in Medicine
  26. Cyclooxygenase as a Target for the Antiamyloidogenic Activities of Nonsteroidal Anti-Inflammatory Drugs in Alzheimer’s Disease
    Giulio Maria Pasinetti · 2002 · Neurosignals
  27. Excessive Alcohol Use as a Risk Factor for Alzheimer’s Disease: Epidemiological and Preclinical Evidence
    Paige E. Anton, Nicole M. Maphis, David N. Linsenbardt, Leon G. Coleman · 2025 · Advances in experimental medicine and biology
  28. Prevention of Cognitive Impairment in the Midlife Women
    Soo Ah Kim, Hyuk Jung · 2015 · Journal of Menopausal Medicine
  29. Alzheimer’s: A Progressive Brain Disease: Causes, Symptoms, and Prevention
    Fakhra Amin, Anas Shamsi, Muhammad Nadeem Asghar, Peerzada Shariq Shaheen Khaki, Mohd Shahnawaz Khan, Shams S. M. Tabrez, Syed Kashif Zaidi, Wajihullah Khan, Bilqees Bano · 2019 · Springer eBooks
  30. Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
    Miren Ettcheto, Elena Sánchez‐López, Amanda C. Cano, Marina Carrasco, Katherine Herrera, Patrícia Regina Manzine, Triana Espinosa-Jiménez, Oriol Busquets, Ester Verdaguer, Jordi Olloquequi et al. · 2021 · Cell & Bioscience
  31. Alzheimer amyloid-β peptides block the activation of C/EBPβ and C/EBPδ in glial cells
    Malin Samuelsson, Veronica Ramberg, Kerstin Iverfeldt · 2008 · Biochemical and Biophysical Research Communications
  32. Differential regulation of prostaglandin synthesis in neonatal rat microglia and astrocytes by somatostatin
    Julia Grinshpun, Liat Tveria, Sigal Fleisher‐Berkovich · 2008 · European Journal of Pharmacology
  33. Mode of Administration-Dependent Brain Uptake of Indomethacin: Sustained Systemic Input Increases Brain Influx
    Arik Dahan, Amnon Hoffman · 2006 · Drug Metabolism and Disposition
  34. Circulating, Cell-Free Micro-RNA Profiles Reflect Discordant Development of Dementia in Monozygotic Twins
    Jonas Mengel‐From, Mette E. Rønne, Anting Liu Carlsen, Kristin Skogstrand, Lisbeth Aagaard Larsen, Qihua Tan, Lene Christiansen, Kaare Christensen, Niels H. H. Heegaard · 2018 · Journal of Alzheimer s Disease
  35. Opposite Modulation of Peripheral Inflammation and Neuroinflammation by Adenosine A2A Receptors
    Rodrigo Antunes Cunha, Jiang‐Fan Chen, Michail V. Sitkovsky · 2007 · Springer eBooks
  36. Electrochemical α-thiolation and azidation of 1,3-dicarbonyls
    Liru Zhu, Yonghong Guo, Bing Zu · 2022 · Chemical Communications
  37. Associations between the use of common nonsteroidal anti-inflammatory drugs, genetic susceptibility and dementia in participants with chronic pain: A prospective study based on 194,758 participants from the UK Biobank
    Shiqi Yuan, Yitong Ling, Xiaxuan Huang, Shanyuan Tan, Wanyue Li, Anding Xu, Jun Lyu · 2023 · Journal of Psychiatric Research
  38. Immune system activation and cognitive impairment in arterial hypertension
    Stefanie Schreiber, Philipp Arndt, Lorena Morton, Alejandra P. Garza, Patrick Müller, Katja Neumann, Hendrik Mattern, Marc Dörner, José Bernal, Stefan Vielhaber et al. · 2024 · American Journal of Physiology-Cell Physiology
  39. ERK pathway activation is required for amyloid-β1–40-induced neurotoxicity of THP-1 human monocytes towards SK-N-SH neuroblastoma
    Linlin Yin, Wei Li, Yanqi Chu, Lin Li · 2011 · Brain Research
  40. The Role of Bromodomain and Extraterminal (BET) Proteins in Controlling the Phagocytic Activity of Microglia In Vitro: Relevance to Alzheimer’s Disease
    Marta Matuszewska, Magdalena Cieślik, Anna Wilkaniec, Marcin Strawski, Grzegorz Arkadiusz Czapski · 2022 · International Journal of Molecular Sciences
  41. Sphingolipids in Neuroinflammation
    Laura Davies, Klaus C Fassbender, Silke Walter · 2013 · Handbook of experimental pharmacology
  42. Plant-based vaccines for Alzheimer's disease: an overview
    Sergio Rosales‐Mendoza, Néstor Rubio‐Infante, Sergio Zarazúa, Dania O. Govea‐Alonso, Guadalupe Martel‐Gallegos, Leticia Moreno‐Fierros · 2014 · Expert Review of Vaccines
  43. Upregulation of CBLL1 in rat brain cortex after lipopolysaccharide treated
    Maohong Cao, Heyi Zheng, Xiang Tan et al. · 2012 · Journal of Molecular Histology
  44. Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test
    Amod P. Kulkarni, Nirvana Pillay, Lauriston A. Kellaway · 2008 · Biogerontology
  45. Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β
    Thomas J. Anastasio · 2014 · Molecular BioSystems
  46. Indomethacin enhances learning and memory potential by interacting with CaMKII
    Takeshi Kanno, Takahiro Yaguchi, Tetsu Nagata, Tadashi Shimizu, Akito Tanaka, Tomoyuki Nishizaki · 2011 · Journal of Cellular Physiology
  47. No apparent effect of naproxen on CSF markers of innate immune activation
    Pierre‐François Meyer, Anne Labonté, Pedro Rosa‐Neto, Judes Poirier, John C.S. Breitner · 2019 · Annals of Clinical and Translational Neurology
  48. Pathobiolgy and Management of Alzheimer's Disease
    Hoowon Kim, Ji Yeon Chung · 2021 · Chonnam Medical Journal
  49. Alzheimer's disease: overview
    David F. Tang‐Wai, Keith A. Josephs, Ronald Carl Petersen · 2005 · Cambridge University Press eBooks
  50. The cyclopentenone 15-deoxy-Δ12,14-prostaglandin J2 inhibits G1/S transition and retinoblastoma protein phosphorylation in immortalized lymphocytes from Alzheimer's disease patients
    Úrsula Muñoz, Natividad de las Cuevas, Fernando Benito Bartolomé, Ofelia García Hermida, Fẽlix Bermejo, Ángeles Martín‐Requero · 2005 · Experimental Neurology
  51. Indomethacin Activates Protein Kinase C and Potentiates α7 ACh Receptor Responses
    Takeshi Kanno, Takahiro Yaguchi, Tetsu Nagata · 2012 · Cellular Physiology and Biochemistry
  52. What role do community pharmacists currently play in the management of headache? A hospital-based perspective
    K K Gahir, Andrew J. Larner · 2004 · International Journal of Clinical Practice
  53. Acetylsalicylic acid as an adjuvant therapy for schizophrenia
    Wijnand Laan, Jean‐Paul Selten, René S. Kahn, Anne-Margriet Huisman, Cobi J. Heijnen, Diederick E. Grobbee, Huibert Burger · 2006 · Trials
  54. Cytokines and the ageing brain
    Colm M. Cunningham, Jan Pieter Konsman, Tammy Cartmell · 2002 · Trends in Neurosciences
  55. A retrospective evaluation of the effect of hydroxyquinine on RPE thickness
    Joseph Pikkel, Otzem Chassid, Adi Sharabi‐Nov · 2013 · Graefe s Archive for Clinical and Experimental Ophthalmology
  56. Prevention and Therapy of Neurodegenerative Disorders: Role of Nutritional Antioxidants
    Vincenzo Di Matteo, Massimo Pierucci, Giuseppe Di Giovanni, Ennio Esposito · 2007 · Elsevier eBooks
  57. Post intoxicative therapeutic immunization with myelin oligodendrocyte glycoproteine (MOG 35-55) suppresses spontaneous regeneration of dopaminergic neurons injured with 1-methyl-4 phenyl-1,2,3,6-tetrahydropiridine (MPTP)
    Ewa Bałkowiec-Iskra, Iwona Kurkowska‐Jastrzębska, Ilona Joniec‐Maciejak · 2003 · Acta Neurobiologiae Experimentalis
  58. The influence of chronic ibuprofen treatment on proteins expressed in the mouse hippocampus
    Kenji Matsuura, Mieko Otani, Masaoki Takano, Keiichi Kadoyama, Shogo Matsuyama · 2015 · European Journal of Pharmacology
  59. Differential burden of rare protein truncating variants in Alzheimer’s disease patients compared to centenarians
    Yun Freudenberg‐Hua, Wentian Li, Avinash Abhyankar, Vladimir Vacic, Vanessa Rodrigues Paixão Côrtes, Danny Ben‐Avraham, Jeremy L. Koppel, BLAINE S. GREENWALD, Søren Germer, Robert B. Darnell et al. · 2016 · Human Molecular Genetics
  60. Detangling Alzheimer's Disease
    Laura L. Helmuth · 2003 · Science of Aging Knowledge Environment
  61. Microglial Immunoregulation by Apoptotic Cellular Membrane Mimetic Polymeric Particles
    Yasuhiro Nakagawa, Jeonggyu Lee, Yihua Liu, Saed Abbasi, Taehun Hong, Horacio Cabral, Satoshi Uchida, Mitsuhiro Ebara · 2022 · ACS Macro Letters
  62. Is Alzheimer's Disease a Synaptic Disorder?
    Massimiliano Pomponi, Pietro Bria, Massimo F L Pomponi · 2008 · Journal of Alzheimer s Disease
  63. Prevention of Alzheimer’s disease: Where we stand
    Mary Sano · 2002 · Current Neurology and Neuroscience Reports
  64. NSAID and Alzheimer's disease; possible answers and new questions
    Kenneth L. Davis · 2002 · Molecular Psychiatry
  65. Long‐term cognitive benefits of donepezil in Alzheimer’s disease: A retrospective comparison between 1994–1999 and 2000–2004
    Naoki Tomita, Mari Ootsuki, Masahiro Maruyama, Toshifumi Matsui, M. Higuchi, Miho Tsutsui, Takashi Seki, Koh Iwasaki, Masako Tamamizu, Takashi Sozu et al. · 2007 · Geriatrics and gerontology international/Geriatrics & gerontology international
  66. Preparation, transportation mechanisms and brain-targeting evaluationin vivoof a chemical delivery system exploiting the blood–cerebrospinal fluid barrier
    Ling Li, Jue Tuo, Yanqi Xie · 2014 · Journal of drug targeting
  67. Methodological issues in a cluster-randomized trial to prevent dementia by intensive vascular care
    Edo Richard, Suzanne A. Ligthart, Eric P. Moll van Charante · 2010 · The journal of nutrition health & aging
  68. Neuronal zinc stores are modulated by non-steroidal anti-inflammatory drugs: An optical analysis in cultured hippocampal neurons
    Rachal Love, Gloria Salazar, Victor Faúndez · 2005 · Brain Research
  69. Effects of Probiotics on Colitis-Induced Exacerbation of Alzheimer’s Disease in AppNL-G-F Mice
    Bijayani Sahu, Lauren M. Johnson, Mona Sohrabi, Anastasia A. Usatii, Rachel M. J. Craig, Joshua B. Kaelberer, Sathiya Priya Chandrasekaran, Harpreet Kaur, Suba Nookala, Colin Kelly Combs · 2023 · International Journal of Molecular Sciences
  70. Role of Nonsteroidal Anti-Inflammatory Drugs as a Protective Factor in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
    Akash Asthana, Shashank Tripathi, Rachna Agarwal · 2024 · Neurology India
  71. Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor
    Manman Dong, Yongli Lu, Yunhong Zha, Hongwei Yang · 2014 · Journal of Molecular Neuroscience
  72. Therapeutic roles of plants for 15 hypothesised causal bases of Alzheimer’s disease
    Sheena E.B. Tyler, Luke D.K. Tyler · 2022 · Natural Products and Bioprospecting
  73. Pharmacotherapy for Alzheimerʼs disease and other dementias
    Nathan Herrmann · 2002 · Current Opinion in Psychiatry
  74. Roles of Toll-Like Receptors in Pathophysiology of Alzheimer’s Disease and Multiple Sclerosis
    Shyamal C. Bir, Oleg Y. Chernyshev, Alireza Minagar · 2018 · Elsevier eBooks
  75. Inflammation Spreading: Negative Spiral Linking Systemic Inflammatory Disorders and Alzheimer’s Disease
    Junjun Ni, Zhou Wu · 2021 · Frontiers in Cellular Neuroscience
  76. Sociodemographic and Clinical Correlates of Utility Scores in Alzheimer's Disease
    Edward Alan Miller, Lon S. S. Schneider, Arthur S. Zbrozek, Robert Alan Rosenheck · 2008 · Value in Health
  77. Chronic HIV infection leads to an Alzheimer's disease like illness. Involvement of the kynurenine pathway
    Gilles J. Guillemin, Bruce James Brew · 2007 · International Congress Series
  78. MxA Polymorphisms Are Associated with Risk and Age-at-Onset in Alzheimer Disease and Accelerated Cognitive Decline in Chinese Elders
    Suk Ling Ma, Wei Huang, Nelson L.S. Tang, LINDA C. W. LAM · 2012 · Rejuvenation Research
  79. Profiles of COX-2 inhibitors: present and future
    Shin Chung, Kyung‐Min Lim, Song Seok Shin · 2005 · Expert Opinion on Therapeutic Patents
  80. Forecasting the Nursing Home Population
    Kenneth G. Mantón · 2003 · Medical Care
  81. Impaired regulation of immune responses in cognitive decline and Alzheimer’s disease: lessons from genetic association studies
    Martina Chiappelli, Emanuela Tumini, Elisa Porcellini, Federico Licastro · 2006 · Expert Review of Neurotherapeutics
  82. The Application of Evidence-Based Principles of Care in Older Persons (Issue 5): Alzheimer’s Disease
    Barbara J.M. Zarowitz, Richard G. Stefanacci, Kelly A. Hollenack, Terry O’Shea, Joseph Gruber, Eric G. Tangalos · 2006 · Journal of the American Medical Directors Association
  83. Neuropathological Verisimilitude in Animal Models of Alzheimer's Disease
    John Q. Trojanowski · 2002 · American Journal Of Pathology
  84. Cyclo-oxygenase inhibitors and Alzheimer's: are we well ADAPTed?
    Giulio Maria Pasinetti, Patrick N. Pompl · 2002 · The Lancet Neurology
  85. Medication Exposure and Risk of Dementia and Alzheimer’s Disease
    Niti Sharma, Seong Soo A. An, SangYun Kim · 2024 · International Journal of Molecular Sciences
  86. Versatile Synthesis of Organic Compounds Derived from Ascorbic Acid
    Aparna Das, Bimal Krishna Banik · 2021 · Current Organocatalysis
  87. The Human Leukocyte Antigen Class III Haplotype Approach: New Insight in Alzheimer's Disease Inflammation Hypothesis
    Elisa Maggioli, Chiara Boiocchi, Michele Zorzetto, Elena Sinforiani, Cristina Cereda, Giovanni Ricevuti, Mariaclara Cuccia · 2013 · Current Alzheimer Research
  88. Seeking a New Paradigm for Alzheimer’s Disease: Considering the Roles of Inflammation, Blood-Brain Barrier Dysfunction, and Prion Disease
    Mark E. McCaulley, Kira A. Grush · 2017 · International Journal of Alzheimer s Disease
  89. Effect of Pain Severity on Executive Function Decline in Community-Dwelling Older Adults
    Shunsuke Murata, Sho Nakakubo, Tsunenori Isa, Yamato Tsuboi, Kohtaroh Torizawa, Akimasa Fukuta, Maho Okumura, Naoka Matsuda, Rei Ono · 2018 · Gerontology and Geriatric Medicine
  90. Dementia, the fate of brain? Neuropathological point of view
    Jean‐Jacques Hauw, Charles J. Duyckaerts · 2002 · Comptes Rendus Biologies
  91. Treatment of Alzheimer's disease in Brazil: I. Cognitive disorders
    Francisco de Assis Carvalho do Vale, Ylmar Corrêa Neto, Paulo Henrique Ferreira Bertolucci, João Carlos Barbosa Machado, Delson José da Silva, Nasser Allam, Márcio Luiz Figueredo Balthazar · 2011 · Dementia & Neuropsychologia
  92. Deficiency in either COX-1 or COX-2 genes does not affect amyloid beta protein burden in amyloid precursor protein transgenic mice
    Sun Ah Park, Nathalie Chevallier, Karishma Tejwani, Mary M. Hung, Hiroko Maruyama, Todd Eliot Golde, Edward H. Koo · 2016 · Biochemical and Biophysical Research Communications
  93. Dietary repletion with ω3 fatty acid or with COX inhibition reverses cognitive effects in F3 ω3 fatty-acid-deficient mice.
    Hafandi Ahmad, Denovan P. Begg, Shirmila D. Premaratna · 2014 · PubMed
  94. A combination of indomethacin and atorvastatin ameliorates cognitive and pathological deterioration in PrP-hAβPPswe/PS1ΔE9 transgenic mice
    Jianhui Wang, Xiaorui Cheng, Xiaorui Zhang, Gang Liu, Yongan Wang, Wenxia Zhou, Yongxiang Zhang · 2019 · Journal of Neuroimmunology
  95. Consideration of a Pharmacological Combinatorial Approach to Inhibit Chronic Inflammation in Alzheimer’s Disease
    James G. McLarnon · 2019 · Current Alzheimer Research
  96. Aging, Neurodegenerative Disease and the Brain
    Edith G. McGeer, Patrick L. McGeer · 1997 · Canadian Journal on Aging / La Revue canadienne du vieillissement
  97. Nonsteroidal Anti-Inflammatory Drugs and Ectodomain Shedding of the Amyloid Precursor Protein
    Stefanie Leuchtenberger, Juan Manuel Maler, Eva Czirr · 2008 · Neurodegenerative Diseases
  98. Scintigraphic visualization of inflammation in neurodegenerative disorders
    Jan J. Versijpt, Koenraad Van Laere, R. A. Dierckx, F. Dumont, P.P. De Deyn, Guido Slegers, Jakob Korf · 2003 · Nuclear Medicine Communications
  99. Sleep Deprivation and Alzheimer’s Disease: A Review of the Bidirectional Interactions and Therapeutic Potential of Omega-3
    Nasar Ullah Khan Niazi, Jiahui Jiang, Haiyan Ou, Ruiye Chen, Zhiyou Yang · 2025 · Brain Sciences
  100. A molecular dynamics investigation of the atomic structural behavior of the interaction between amyloid beta protein and Aspirin within an aqueous nanodomain
    Quynh Hoang Le, Shokoufeh Heydaripour, Bita Farhadi · 2022 · Engineering Analysis with Boundary Elements